Want to join the conversation?
$MDXG said it agreed to buy Stability Biologics, provider of human tissue products. $MDXG sees deal to be accretive to Adjusted EPS in 2016, and sees 2016 Stability Biologics revenues generated from processed tissue and bone product sales and distribution to be at least $15MM. The deal is expected to close by mid-Jan.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.